These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 33002950)

  • 1. Biologics in the treatment of Sjogren's syndrome, systemic lupus erythematosus, and lupus nephritis.
    Narain S; Berman N; Furie R
    Curr Opin Rheumatol; 2020 Nov; 32(6):609-616. PubMed ID: 33002950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updates on B-cell immunotherapies for systemic lupus erythematosus and Sjogren's syndrome.
    Coca A; Sanz I
    Curr Opin Rheumatol; 2012 Sep; 24(5):451-6. PubMed ID: 22871954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B cell depletion in lupus and Sjögren's syndrome: an update.
    Coca A; Sanz I
    Curr Opin Rheumatol; 2009 Sep; 21(5):483-8. PubMed ID: 19644378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic Lupus Erythematosus: A Review.
    Siegel CH; Sammaritano LR
    JAMA; 2024 May; 331(17):1480-1491. PubMed ID: 38587826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological therapy in systemic lupus erythematosus, antiphospholipid syndrome, and Sjögren's syndrome: evidence- and practice-based guidance.
    Marinho A; Delgado Alves J; Fortuna J; Faria R; Almeida I; Alves G; Araújo Correia J; Campar A; Brandão M; Crespo J; Marado D; Matos-Costa J; Oliveira S; Salvador F; Santos L; Silva F; Fernandes M; Vasconcelos C
    Front Immunol; 2023; 14():1117699. PubMed ID: 37138867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CD5 and CD23 on B cells of patients with rheumatoid arthritis, systemic lupus erythematosus and Sjögren's syndrome. Relationship with disease activity and treatment.
    Ebo D; DeClerck LS; Bridts CH; Stevens WJ
    In Vivo; 1994; 8(4):577-80. PubMed ID: 7534494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple dermatofibromas in a patient with systemic lupus erythematosus and Sjögren's syndrome.
    Fujisawa T; Seishima M
    Mod Rheumatol; 2010 Aug; 20(4):396-400. PubMed ID: 20221662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of methotrexate in patients with systemic lupus erythematosus and primary Sjögren's syndrome.
    Winzer M; Aringer M
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S156-9. PubMed ID: 21044451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Epratuzumab, an Anti-CD22 Monoclonal IgG Antibody, in Systemic Lupus Erythematosus Patients With Associated Sjögren's Syndrome: Post Hoc Analyses From the EMBODY Trials.
    Gottenberg JE; Dörner T; Bootsma H; Devauchelle-Pensec V; Bowman SJ; Mariette X; Bartz H; Oortgiesen M; Shock A; Koetse W; Galateanu C; Bongardt S; Wegener WA; Goldenberg DM; Meno-Tetang G; Kosutic G; Gordon C
    Arthritis Rheumatol; 2018 May; 70(5):763-773. PubMed ID: 29381843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lupus Nephritis: New and Emerging Biologic and Targeted Therapies.
    Kale A; Lech M; Anders HJ; Gaikwad AB
    BioDrugs; 2023 Jul; 37(4):463-475. PubMed ID: 37093522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular targeting in autoimmunity.
    Rogers JL; Serafin DS; Timoshchenko RG; Tarrant TK
    Curr Allergy Asthma Rep; 2012 Dec; 12(6):495-510. PubMed ID: 23054625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologics in Sjögren's syndrome.
    Skarlis C; Marketos N; Mavragani CP
    Pharmacol Res; 2019 Sep; 147():104389. PubMed ID: 31415917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practical use of immunosuppressive drugs in autoimmune rheumatic diseases.
    De Jesus A; Talal N
    Crit Care Med; 1990 Feb; 18(2 Suppl):S132-7. PubMed ID: 2298028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary cryptococcosis in childhood systemic lupus erythematosus and Sjögren syndrome overlap: a rare opportunistic infection.
    Marques VL; Gomes RC; Viola GR; Maia MM; Durigon GS; Aikawa NE; Artur Silva C
    Lupus; 2013 Nov; 22(13):1409-12. PubMed ID: 23985965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren's syndrome differ in molecular signatures and treatment perspectives.
    Idborg H; Zandian A; Sandberg AS; Nilsson B; Elvin K; Truedsson L; Sohrabian A; Rönnelid J; Mo J; Grosso G; Kvarnström M; Gunnarsson I; Lehtiö J; Nilsson P; Svenungsson E; Jakobsson PJ
    Arthritis Res Ther; 2019 Feb; 21(1):62. PubMed ID: 30777133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of B lymphocyte stimulator inhibitor belimumab may be associated with a decrease in the serum concentration of epidermal growth factor in patients with primary Sjögren's syndrome.
    Kadavath S; Bobic S; Efthimiou P
    Clin Rheumatol; 2015 Sep; 34(9):1651-2. PubMed ID: 25652332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic lupus erythematosus and Sjögren's syndrome induced in a case by interferon-alpha used for the treatment of hepatitis C.
    Onishi S; Nagashima T; Kimura H; Matsuyama Y; Yoshio T; Minota S
    Lupus; 2010 May; 19(6):753-5. PubMed ID: 20064909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
    Ampélas JF; Wattiaux MJ; Van Amerongen AP
    Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic lupus erythematosus and lupus nephritis.
    Koutsokeras T; Healy T
    Nat Rev Drug Discov; 2014 Mar; 13(3):173-4. PubMed ID: 24525782
    [No Abstract]   [Full Text] [Related]  

  • 20. Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases.
    Goules A; Tzioufas AG; Manousakis MN; Kirou KA; Crow MK; Routsias JG
    J Autoimmun; 2006 May; 26(3):165-71. PubMed ID: 16621447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.